Multipoint graphs of the −log10 empirical P value for intraocular pressure adjusted for age, sex, treatment for intraocular pressure, and systolic blood pressure. The horizontal lines depict P value = .01 (−log [P value] = 2.0) and P value = .00074 (Lander and Kruglyak24 suggestive linkage). CM indicates centimorgan.
Duggal P, Klein AP, Lee KE, Klein R, Klein BEK, Bailey-Wilson JE. Identification of Novel Genetic Loci for Intraocular PressureA Genomewide Scan of the Beaver Dam Eye Study. Arch Ophthalmol. 2007;125(1):74-79. doi:10.1001/archopht.125.1.74
JANEY L.WIGGSMD, PhD
To identify genetic loci that control intraocular pressure (IOP).
We performed a genomewide scan of IOP, using 486 pedigrees ascertained through a population-based cohort, the Beaver Dam Eye Study. Linkage analysis was performed using the modified Haseman-Elston regression models and variance components linkage analysis.
Seven regions of interest were identified on chromosomes 2, 5, 6, 7, 12, 15, and 19. The novel linkage region on chromosome 19p had an empirical multipoint P value of 6.1 × 10−5. Two of the regions (2 and 19) were especially interesting since each has been identified as a potential linkage region for blood pressure.
The results of this genomewide scan provide evidence that a quantitative trait locus may influence elevated IOP and may colocalize with blood pressure loci. These loci may control systemic pressure reflected in the eye and vascular system.
Glaucoma is a leading cause of blindness in the world, and the identification of genes that contribute to this disease is essential. Elevated IOP is a principal risk factor for primary open-angle glaucoma and an intriguing quantitative trait that may strongly influence the development of disease.
Primary open-angle glaucoma is a progressive eye disease that often results in blindness. Worldwide, an estimated 37 million people are blind, 12% of whom have blindness attributable to glaucoma.1 Intraocular pressure (IOP) is a physiologic characteristic that is present in every eye and is essential to maintain the structural and functional integrity of the eye. Higher IOP is associated with higher risk of damage to the optic nerve and can result in irreversible vision loss or blindness. Elevated IOP is a primary risk factor for the development of glaucoma.
Several family studies have shown that genetic variation contributes to the development of primary open-angle glaucoma.2- 12 Genetic regions that influence glaucoma have also been identified in large population-based studies.3,10 To fully understand the genetic basis of primary open-angle glaucoma, we focused on the principal risk factor, IOP. The goal of this study was to identify quantitative trait loci controlling IOP across its range of values and thereby influencing the development of glaucoma. The identification of genes that contribute to variation in IOP may help to elucidate the pathologic features and mechanisms that result in vision loss due to glaucoma.
The Beaver Dam Eye Study is a population-based cohort study established in 1988, and a detailed description is available elsewhere.13 Eligibility requirements for inclusion in the study were age between 43 and 84 years and residence in Beaver Dam, Wis. In 1988-1990, a total of 5924 eligible persons was identified by a private census of the community, of whom 4926 (83.1%) participated fully in the baseline evaluation. Family relationships and pedigrees were constructed from participant information and later confirmed at the first follow-up visit (1993-1995). Of the 4926 individuals who enrolled at baseline, 2336 individuals had known familial relationships in the catchment area of the study. For 2044 individuals, we have complete IOP measurements at baseline; DNA for genotypic analysis was available on 1979 individuals. Since the pedigrees were derived from an entire township and eligibility for entry into the study was restricted to generally older individuals, most of the pedigrees are not “deep” or multigenerational. Instead, these pedigrees are “hedges” with multiple siblings, cousins, and spouses but limited parental or grandparental phenotypic information. There are 486 pedigrees (of 602 original pedigrees) used for analysis after excluding families uninformative for linkage (ie, parent-offspring trios). The mean ± SD size of all the pedigrees is 10.5 ± 12.5, and for individuals with both IOP phenotype information and genotype information, it is 4 ± 5. All individuals gave informed consent and the institutional review board at the University of Wisconsin approved all protocols. The National Human Genome Research Institute institutional review board also approved the statistical analyses of these existing data.
Detailed medical histories and eye examinations were performed on all participants, including assessment of IOP and glaucoma. Intraocular pressure was measured using a Goldmann applanation tonometer after instilling a drop of fluorescein combined with a topical anesthetic (Flouress; Barnes-Hind Armour Pharmaceutical Co, Kankakee, Ill) in each eye. The examinations were carried out by trained observers who participated in quality control programs to maintain consistency and validity of measurements.14 Blood pressure was measured according to the Hypertension Detection and Follow-up Program protocol.15 This method entails measuring the blood pressure 3 times, the second and third times with a random-zero sphygmomanometer. The mean of these latter 2 blood pressures was used.
For 76% of individuals, DNA was extracted from buffy coat separated at the time of the blood draw from the second or third Beaver Dam visit and stored at −80° C. For 24% of individuals, DNA was extracted from frozen whole blood cells from the first examination. A genomewide scan was performed at the Center for Inherited Disease Research using automated fluorescent microsatellite analysis. Polymerase chain reaction products were sized using a capillary sequencing platform. The marker set consisted of 404 short tandem repeat markers with an average spacing of 9 centimorgans (cM) throughout the genome. The marker set is a modified version of the Marshfield Genetics (Marshfield, Wis) version 8 screening set with an average heterozygosity of 0.76. The overall missing data rate was 3.5%.
The data were deposited into a Web-based secure database, GeneLink.16 The Center for Inherited Disease Research released the data after running GAS (Genetic Analysis System) to check for mendelian inconsistencies and to identify any systematic laboratory or binning problems. Relationship errors were further identified using PREST17 and RELCHECK,18 which both examine extended pedigrees. The reclassifications of errors resulted in a reduction of 2435 sib pairs to 2427 genotype-verified sib pairs in the full data set. We also identified any residual mendelian errors using MARKERINFO in SAGE version 4.6.19 All errors were corrected prior to any analyses.
For quantitative analyses, the higher IOP measurement from either eye was used. Intraocular pressure was normally distributed and did not need additional transformations. We adjusted for covariates (age, sex, systolic blood pressure, and treatment for IOP) outside of the linkage analysis programs. Using linear regression, we modeled variation in IOP due to these covariates. Then, for each individual, we calculated the predicted deviation from the mean due to that individual's specific values of the covariates and subtracted this from the mean, thus creating a mean-adjusted residual deviation. This adjusted value was then used in our linkage analysis. Intraocular pressure was assessed for deviations from normality using normal quantile plots and measures of skewness and kurtosis. Allele frequencies at marker loci were estimated from founders using the maximum likelihood option in the program FREQ (SAGE version 4.6). Nonparametric linkage analysis was conducted using the Haseman-Elston regression as implemented in SIBPAL (SAGE version 4.6). A weighted combination of squared trait difference and squared mean-corrected trait sum (option W4) was used. This method adjusts for the nonindependence of sib pairs and the nonindependence of squared trait sums and differences. We performed up to 1 million Monte Carlo permutations using SIBPAL to determine the empirical P values.
In addition, we performed variance components analysis using nuclear families in Merlin (version 0.10.2).20 Prior to running variance components in Merlin, our pedigrees were reduced to nuclear families using an option in the statistical program, Mega2.21 Merlin performs multipoint variance components linkage analysis under the assumption of no dominance and calculates the locus-specific heritability for each trait. No ascertainment correction was necessary since the Beaver Dam Eye Study is a population-based cohort. Allele frequencies were calculated in Merlin for founders only. We also performed multipoint variance components using the entire pedigrees in SOLAR (version 2.1.4)22 since it is not limited by larger pedigree size and included covariates in the analysis. Allele frequencies were estimated in FREQ, and identity-by-descent calculations were done within SOLAR for these analyses.
Table 1 provides clinical characteristics for the Beaver Dam Eye Study participants with available IOP measurements and genotype information. Forty-five percent of the individuals were male, and the median age was 62 years for men and 65 years for women. The median IOP measurement was 16 mm Hg and did not differ between sexes. The mean and median IOP measurements (adjusted and unadjusted) were very similar, supporting a normal distribution for this quantitative trait. In addition, we saw no deviation from normality using quantile plots or measures of skewness and kurtosis. One thousand forty-one individuals were classified as having hypertension (systolic blood pressure >139 mm Hg and/or diastolic blood pressure >89 mm Hg and/or taking blood pressure–lowering medication). The mean systolic blood pressure was 133 mm Hg and the mean diastolic blood pressure was 77 mm Hg. Our previous segregation analysis23 showed that age, sex, treatment for IOP, and systolic blood pressure were important covariates in our models, and they were included in all analyses. In total, we had 1979 individuals with both genotype and IOP phenotype information. Of these 1979 participants, there were 1059 full-sib pairs, 59 half-sib pairs, 1567 cousin pairs, 686 avuncular pairs, and 1 grandparent-grandchild pair. Among the 1524 sibships with genotype data, 1293 had 0 parents with phenotype data, 181 had 1 parent with phenotype data, and 50 had 2 parents with phenotype data.
The genomewide scan using Haseman-Elston regression of sib pairs identified 7 regions with an empirical multipoint linkage signal of less than 0.01 (chromosomes 2, 5, 6, 7, 12, 15, and 19). The Figure graphically displays the multipoint linkage regression results for all chromosomes, and Table 2 details the empirical multipoint P values and variance components P values of significance. The strongest evidence for linkage was identified on chromosome 19 near marker D19S586, with single-point and multipoint empirical P values of 2.0 × 10−4 and 6.1 × 10−5, respectively. This novel linkage region reached suggestive evidence for linkage according to the highly conservative Lander and Kruglyak thresholds.24 The chromosome 19 region spans approximately 20 cM with a 1 logarithm of the odds (LOD) drop physical interval from 15 cM to 35 cM.
This same region, near marker D19S586, was also identified in variance components linkage analysis of the nuclear family data (P value = .005; locus-specific h2 = 28.4%). Of the 6 additional regions identified by Haseman-Elston regression, 5 were also supported with variance components analysis of the nuclear family data (Table 2) with locus-specific heritability ranging from 20% to 28%. Additionally, we performed variance components linkage analysis using extended pedigree data; however, we did not identify any regions that reached a LOD score of 2.0 or greater. Using the entire pedigree, we identified 3 regions with a LOD score of 1.0 or greater: chromosome 15 (71 cM) with a LOD score of 1.59 and a locus-specific heritability of 22%, chromosome 12 (88 cM) with a LOD score of 1.28 and a locus-specific heritability of 20%, and chromosome 7 (64 cM) with a LOD score of 1.43 and a locus-specific heritability of 20%.
We performed a genomewide scan of IOP in families from a population-based cohort, the Beaver Dam Eye Study. The region providing the strongest evidence of linkage was on chromosome 19p near marker D19S586. Analysis using both Haseman-Elston regression of sibling data (P value = .00006) and variance components analysis of nuclear family data (P value = .005) supported linkage of IOP to this same region on chromosome 19. Intriguingly, this telomeric region of 19p also yielded suggestive evidence for linkage (LOD = 2.3) in a genomewide scan for systolic blood pressure in 18 Dutch families with dyslipidemia.25 This region has also been identified as highly suggestive for systolic blood pressure (LOD = 2.1; P value = .00094) in a study of 206 families in the Quebec Family Study.26 In a study of sib pairs with hypertension (black and white) from the HyperGEN Network, a small peak (LOD = 1.31) was also reported within this region (24 cM) among white sib pairs27 These are sibling pairs with hypertension diagnosed before 60 years of age and without type 1 diabetes mellitus. More recently, a study of pulse pressure (the difference between systolic and diastolic blood pressure) in the Family Blood Pressure Program, which includes black, Asian, Hispanic, and white families, found evidence for linkage (LOD = 3.1) to this same locus among black and white individuals.28 Our evidence for a quantitative trait loci for IOP coupled with these studies of hypertension, systolic blood pressure, or pulse pressure all suggest that this region shows strong evidence of harboring a quantitative trait gene related to both IOP and systemic blood pressure.
Although the linkage peak on chromosome 2 was not substantiated using variance components, this region is still of strong interest since it also appears to colocalize with a blood pressure locus. In the Quebec Family Study, Rice and colleagues26 found suggestive evidence for linkage of systolic blood pressure (LOD = 2.26; P value = .00062) within the same 20-cM region on chromosome 2. Additionally, in a study of pulse pressure in Mexican American individuals from the San Antonio Family Heart Study, a linkage peak of 1.28 was found at marker D2S1790, which is within 4 cM of our locus.29 This region on chromosome 2 has also been identified as a glaucoma locus, GLC1B. In an initial study of 6 families with glaucoma, Stoilova and colleagues7 found significant linkage with a maximum parametric LOD score of 6.48. Recently, a study of a single 4-generation, Tasmanian family with glaucoma, which included 15 living descendants, identified a 9-cM region on chromosome 2 (exact nonparametric linkage = 0.005) that overlaps with GLC1B, confirming this as a glaucoma locus.30 Our findings suggest that this region on chromosome 2 may harbor a single gene that influences systemic blood pressure, with strong effects on glaucoma, or possibly 2 or more genes in close proximity that influence pressure and glaucoma independently.
It is not surprising that 2 of our linkage regions appear to colocalize with blood pressure loci. A previous analysis in the Beaver Dam Eye Study demonstrated a significant correlation of IOP with systolic and diastolic blood pressures at baseline and follow-up.31 For a 10–mm Hg increase in systolic blood pressure or diastolic blood pressure, there was a 0.21–mm Hg increase (95% confidence interval, 0.16-0.27 mm Hg) and 0.43–mm Hg increase (95% confidence interval, 0.35-0.52 mm Hg) in IOP, respectively. This study showed that systemic blood pressure and IOP may be intertwined and intimates that a common mechanism or gene may be controlling pressure in the eye and vascular system.
Interestingly, we did not replicate our own pilot linkage analysis of IOP in the Beaver Dam Eye Study.23 In our previous study, we performed linkage analysis using 263 sibling pairs from 102 pedigrees previously selected for age-related maculopathy and identified 2 interesting potential linkage regions on chromosomes 6 (P value = .008) and 13 (P value = .0007). However, after expanding our study to include more individuals (n = 1979) and pedigrees (n = 486) and using a population-based sample not selected for any other traits, these previous linkage regions were no longer significant. This is not particularly surprising since the initial pilot study used a minimal sample of individuals compared with our more complete, current study, and neither region on chromosome 6 or 13 was significant using Lander and Kruglyak24 thresholds of significance. However, this further highlights the importance of replication or confirmation studies for any important epidemiologic or genetic findings.
It was revealing that for this quantitative trait the most powerful method of analysis was Haseman-Elston regression using sibling pairs. Analysis of complete pedigrees using variance components found limited evidence for linkage. This is most likely due to the type of pedigrees in the Beaver Dam Eye Study. Unlike more traditional linkage studies that aim to maximize information using multigenerational pedigrees with affected individuals across generations, the Beaver Dam Eye Study pedigrees were derived from a population-based cohort study, and age at enrollment was 43 to 86 years. Although these pedigrees are large, they most often lack a parental generation for both phenotype and genotype information and comprise predominantly sibships and cousin pairs. In this case, the major contributors to linkage information were sib pairs or individuals within a nuclear family. The use of the entire hedge pedigree may have introduced heterogeneity for this complex trait from extreme branches of the pedigrees where variation was controlled by different IOP genes. We know from studies of glaucoma and blood pressure that it is unlikely that only 1 gene controls IOP, and the use of the larger pedigrees may have actually diluted our findings. However, we are reassured that both nuclear-family methods, the Haseman-Elston regression and Merlin variance components, identified the same regions. Additionally, for 3 of our loci, variance components using the entire pedigrees also highlighted the same regions. For these population-based pedigrees, using nuclear families appears to be the most powerful method for the identification of linkage peaks for traits hypothesized to be genetically heterogenous (both locus and allelic).
In summary, we report the results of our initial genomewide scan for IOP and identify 7 loci of interest. Each of these loci deserves further attention, and they will hopefully be replicated in additional populations or further refined with dense single nucleotide polymorphism fine mapping to identify the genes controlling IOP. Two of our regions colocalize with blood pressure loci and suggest that a gene or genes at chromosomes 19p (genomewide suggestive linkage) and 2p may control pressure in the eye and blood. Understanding the mechanism of elevated IOP may help elucidate our understanding of both hypertension and glaucoma.
Correspondence: Priya Duggal, PhD, MPH, Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, 333 Cassell Dr, Suite 1200, Baltimore, MD 21210 (firstname.lastname@example.org).
Submitted for Publication: June 24, 2006; final revision received August 11, 2006; accepted August 15, 2006.
Author Contributions: Dr Duggal had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Financial Disclosure: None reported.
Funding/Support: The results of this article were obtained by using the program package SAGE, which is supported by US Public Health Service Resource Grant RR03665 from the National Center for Research Resources, Bethesda, Md. This research was supported by grants R01 EY015286 (Dr B. E. K. Klein) and U10 EY06594 (Drs R. Klein and B. E. K. Klein) from the National Eye Institute and in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. Drs R. Klein and B. E. K. Klein are recipients of Senior Investigator Awards from Research to Prevent Blindness, New York, NY.
Acknowledgment: We are grateful to the participants of the Beaver Dam Eye Study.